InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
0.281
-0.009 (-3.24%)
At close: Sep 12, 2024, 4:00 PM
0.270
-0.011 (-3.78%)
Pre-market: Sep 13, 2024, 6:33 AM EDT
InMed Pharmaceuticals Employees
InMed Pharmaceuticals had 13 employees as of June 30, 2023. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$432,748
Profits / Employee
-$467,405
Market Cap
2.50M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Scorpius Holdings | 84 |
Nuwellis | 59 |
iSpecimen | 53 |
Sintx Technologies | 43 |
FOXO Technologies | 29 |
Bio-Path Holdings | 10 |
Phio Pharmaceuticals | 9 |
Quoin Pharmaceuticals | 4 |
INM News
- 22 days ago - InMed Pharmaceuticals Strengthens Patent Portfolio with Issuance of Three U.S. Patents - Newsfile Corp
- 23 days ago - InMed Pharmaceuticals Advances Oral Candidate For Alzheimer's Disease, Stock Surges On Tuesday - Benzinga
- 23 days ago - InMed Pharmaceuticals Demonstrates INM-901 as an Oral Formulation Targeting Alzheimer's Disease - Newsfile Corp
- 6 weeks ago - InMed Pharmaceuticals Announces Favorable Behavioral Outcomes with INM-901 in Long-Term Preclinical Alzheimer's Disease Study, Confirming Previous Short-Term Pilot Study Data - Newsfile Corp
- 3 months ago - InMed to Present at the Emerging Growth Conference - Newsfile Corp
- 4 months ago - InMed Pharmaceuticals Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update - Newsfile Corp
- 5 months ago - InMed Appoints Dr. David G. Morgan, PhD, a Leading Alzheimer's Expert, to the Company's Scientific Advisory Board - Newsfile Corp
- 5 months ago - InMed Provides Update on INM-089 in the Treatment of Dry Age-Related Macular Degeneration - Newsfile Corp